The drug company Eli Lilly is suing four telehealth companies for allegedly selling copies made by compounding pharmacies of ...

Lilly is using a new line of attack against telehealth firms, accusing them in lawsuits of engaging in the corporate practice ...

Novo Nordisk submitted an oral version of the weight-loss formulation of semaglutide (Wegovy) for FDA approval, according to ...

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

Novo Nordisk's booming obesity drugs & diabetes portfolio make it a top growth play. Click here to read an analysis of NVO ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

We recently published a list of 10 Best Low Volatility Stocks to Buy Now. In this article, we are going to take a look at ...

A North Texas hospital system has filed a lawsuit over insulin pricing, joining a growing rank of plaintiffs who are suing manufacturers and others on the grounds of inflating prices of the vital drug ...

President Donald Trump has ordered the Department of Health and Human Services to standardize Medicare payments in an effort ...

When Lily Nichols, a mother of two and neonatal intensive care unit nurse, became pregnant, she felt comfortable going into ...

Arlington-based Texas Health Resources is suing six drugmakers and pharmacy benefit managers, alleging the parties colluded to drive up the price of insulin, according to court documents obtained by ...